Literature DB >> 17915935

Peptide-functionalized poly(ethylene glycol) star polymers: DNA delivery vehicles with multivalent molecular architecture.

Katye M Fichter1, Le Zhang, Kristi L Kiick, Theresa M Reineke.   

Abstract

Exploring the development of nonviral nucleic acid delivery vectors with progressive, specific, and novel designs in molecular architecture is a fundamental way to investigate how aspects of chemical and physical structure impact the transfection process. In this study, macromolecules comprised of a four-arm star poly(ethylene glycol) and termini modified with one of five different heparin binding peptides have been investigated for their ability to bind, compact, and deliver DNA to mammalian cells in vitro. These new delivery vectors combine a PEG-derived stabilizing moiety with peptides that exhibit unique cell-surface binding ability in a molecular architecture that permits multivalent presentation of the cationic peptides. Five peptide sequences of varying heparin binding affinity were studied; each was found to sufficiently bind heparin for biological application. Additionally, the macromolecules were able to bind and compact DNA into particles of proper size for endocytosis. In biological studies, the PEG-star peptides displayed a range of toxicity and transfection efficiency dependent on the peptide identity. The vectors equipped with peptides of highest heparin binding affinity were found to bind DNA tightly, increase levels of cellular internalization, and display the most promising transfection qualities. Our results suggest heparin binding peptides with specific sequences hold more potential than nonspecific cationic polymers to optimize transfection efficiency while maintaining cell viability. Furthermore, the built-in multivalency of these macromolecules may allow simultaneous binding of both DNA at the core of the polyplex and heparan sulfate on the surface of the cell. This scheme may facilitate a bridging transport mechanism, tethering DNA to the surface of the cell and subsequently ushering therapeutic nucleic acids into the cell. This multivalent star shape is therefore a promising architectural feature that may be exploited in the design of future polycationic gene delivery vectors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17915935      PMCID: PMC2650482          DOI: 10.1021/bc0701141

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  60 in total

1.  Key issues in non-viral gene delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-10-05       Impact factor: 15.470

2.  Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes.

Authors:  C Plank; M X Tang; A R Wolfe; F C Szoka
Journal:  Hum Gene Ther       Date:  1999-01-20       Impact factor: 5.695

Review 3.  Clathrin-dependent or not: is it still the question?

Authors:  Ludger Johannes; Christophe Lamaze
Journal:  Traffic       Date:  2002-07       Impact factor: 6.215

Review 4.  Cell-specific targeting of lipid-based carriers for ODN and DNA.

Authors:  Martin Bartsch; Alida H Weeke-Klimp; Dirk K F Meijer; Gerrit L Scherphof; Jan A A M Kamps
Journal:  J Liposome Res       Date:  2005       Impact factor: 3.648

Review 5.  Intracellular trafficking of nonviral vectors.

Authors:  L K Medina-Kauwe; J Xie; S Hamm-Alvarez
Journal:  Gene Ther       Date:  2005-12       Impact factor: 5.250

6.  A natural motif approach to protein design: a synthetic leucine zipper peptide mimics the biological function of the platelet factor 4 protein.

Authors:  D J Butcher; M A Kowalska; S Li; Z Luo; S Shan; Z Lu; S Niewiarowski; Z Huang
Journal:  FEBS Lett       Date:  1997-06-09       Impact factor: 4.124

7.  Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types.

Authors:  T J Wickham; P W Roelvink; D E Brough; I Kovesdi
Journal:  Nat Biotechnol       Date:  1996-11       Impact factor: 54.908

8.  Importance of specific amino acids in protein binding sites for heparin and heparan sulfate.

Authors:  E E Caldwell; V D Nadkarni; J R Fromm; R J Linhardt; J M Weiler
Journal:  Int J Biochem Cell Biol       Date:  1996-02       Impact factor: 5.085

9.  Formation of DNA nanoparticles in the presence of novel polyamine analogues: a laser light scattering and atomic force microscopic study.

Authors:  Veena Vijayanathan; Thresia Thomas; Thomas Antony; Akira Shirahata; T J Thomas
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

10.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Authors:  Dagmar Fischer; Youxin Li; Barbara Ahlemeyer; Josef Krieglstein; Thomas Kissel
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

View more
  5 in total

1.  Polymer-Based Therapeutics.

Authors:  Shuang Liu; Ronak Maheshwari; Kristi L Kiick
Journal:  Macromolecules       Date:  2009-01-13       Impact factor: 5.985

Review 2.  Applications of orthogonal "click" chemistries in the synthesis of functional soft materials.

Authors:  Rhiannon K Iha; Karen L Wooley; Andreas M Nyström; Daniel J Burke; Matthew J Kade; Craig J Hawker
Journal:  Chem Rev       Date:  2009-11       Impact factor: 60.622

3.  Polymeric nucleic acid vehicles exploit active interorganelle trafficking mechanisms.

Authors:  Katye M Fichter; Nilesh P Ingle; Patrick M McLendon; Theresa M Reineke
Journal:  ACS Nano       Date:  2012-12-31       Impact factor: 15.881

4.  Synthesis of Heterotelechelic Polymers for Conjugation of Two Different Proteins.

Authors:  Karina L Heredia; Gregory N Grover; Lei Tao; Heather D Maynard
Journal:  Macromolecules       Date:  2009       Impact factor: 5.985

Review 5.  Structurally nanoengineered antimicrobial peptide polymers: design, synthesis and biomedical applications.

Authors:  Ronisha Ramamurthy; Chetan H Mehta; Usha Y Nayak
Journal:  World J Microbiol Biotechnol       Date:  2021-07-19       Impact factor: 3.312

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.